Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Cash on Hand
Cash on Hand as of December 2023 : $0.31 B
According to Collegium Pharmaceutical
's latest financial reports the company has $0.31 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Collegium Pharmaceutical - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.31 B | 78.8% |
| 2022-12-31 | $0.17 B | -6.83% |
| 2021-12-31 | $0.18 B | 7.07% |
| 2020-12-31 | $0.17 B | 2.41% |
| 2019-12-31 | $0.17 B | 15.95% |
| 2018-12-31 | $0.14 B | 23.54% |
| 2017-12-31 | $0.11 B | -22.53% |
| 2016-12-31 | $0.15 B | 60.11% |
| 2015-12-31 | $95.69 M | 5756.61% |
| 2014-12-31 | $1.63 M | -78.36% |
| 2013-12-31 | $7.55 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | $2.99 B | 864.13% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.87 M | -99.07% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.46 B | 693.64% | 🇮🇪 Ireland |
 KemPharm KMPH | $82.84 M | -73.32% | 🇺🇸 USA |